Persist AI

About

It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.

Founders

• 
  Karthik Raman· Founder

  When mom got brain cancer, I used to take her for her "infusions". For 4 hours, we would sit there while drug was being infused into her veins and she had horrible nausea and hair loss. I built Persist to eradicate this horrible experience for future patients. We package drugs so that patients take 1 injection per month or year, without an infusion. This lowers the overall dose the patient receives (reducing side-effects), improves compliance, and quality of life.

  LinkedIn ↗
• 
  Christopher Shelner· Founder

  Career program manager, first time founder. Focus has been in electronics, automation, and manufacturing. Super excited to be part of the YC batch!

  LinkedIn ↗

Product launches · 1 launch

• Persist - We build long-lasting drugs 50% faster 💊 ↗▲ 36Feb 13, 2023

  Drug formulations made by robotics and designed by AI

Change history · none recorded